Although maintaining the integrity of the central nervous system (CNS) is of extreme importance to human health and function, relatively little is known about the signaling processes involved in the proliferation, differentiation and survival of CNS neurons. Two growth factors, epidermal growth factor (EGF) and fibroblast-derived growth factor (FGF), have been implicated as mitogens, differentiating agents, and neurotrophic agents for neuronal stem cells and neurons in a number of CNS regions, including the hippocampus. The hippocampal-septal axis plays a key role in learning and memory, is involved in many neuropathies including Alzheimer's disease, epilepsy and stroke, and has a relative structural simplicity which has proven useful in studies of development and plasticity. In order to investigate the mechanism by which growth factors influence hippocampal development and function, we have generated neuronal cell lines of hippocampal lineage that proliferate in response to EGF and differentiate into a nonproliferating, neuronal phenotype in response to bFGF. In the present proposal, we will focus on the mechanism by which growth factors differentiate neuronal cells. We propose to use these cell lines to define major signalling intermediates in the bFGF signal transduction pathways and test the hypothesis that these intermediates are responsible for the actions of bFGF as a differentiating agent/ Specifically, we plan to identify activated intermediates in the FGF signal transduction pathway, determine the role of activated intermediates in the FGF signaling pathway, and identify and characterize genes that may code for novel intermediates in the signaling pathways leading to differentiation of H19-7 cells. The results of these studies will define key signaling intermediates that influence neuronal differentiation and increase our understanding of the processes that lead to neoplastic transformation and neurodegenerative disease involving neuronal differentiation and survival.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS033858-03
Application #
2416375
Study Section
Neurology B Subcommittee 2 (NEUB)
Program Officer
Cheung, Mary Ellen
Project Start
1995-05-01
Project End
1999-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Minn, Andy J; Bevilacqua, Elena; Yun, Jieun et al. (2012) Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle 11:2452-7
Granovsky, Alexey E; Clark, Matthew C; McElheny, Dan et al. (2009) Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism. Mol Cell Biol 29:1306-20
Shemon, Anne N; Eves, Eva M; Clark, Matthew C et al. (2009) Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration. PLoS One 4:e6028
Dangi-Garimella, Surabhi; Yun, Jieun; Eves, Eva M et al. (2009) Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 28:347-58
Zeng, Lingchun; Imamoto, Akira; Rosner, Marsha Rich (2008) Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets 12:1275-87
Granovsky, Alexey E; Rosner, Marsha Rich (2008) Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 18:452-7
Eves, Eva M; Shapiro, Paul; Naik, Karuna et al. (2006) Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 23:561-74
Trakul, Nicholas; Menard, Raymond E; Schade, George R et al. (2005) Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem 280:24931-40
Hong, Jia; Beeler, Jeff; Zhukovskaya, Natalia L et al. (2005) Anthrax edema factor potency depends on mode of cell entry. Biochem Biophys Res Commun 335:850-7
Lin, Clark; Franco, Brunella; Rosner, Marsha Rich (2005) CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet 14:3775-86

Showing the most recent 10 out of 29 publications